Mead Johnson Nutrition, the infant formula maker, was the top gainer on the S&P 500. The stock gained 11.1 per cent to $83.79 amid chatter that it could be the target of takeover interest. The $15bn company behind the Enfamil brand of baby formula has been the subject of frequent mergers and acquisition rumours, with France’s Danone seen as the most logical suitor.